In fiscal 2025, which ended Dec 31, 2025, Clover Health Investments, Corp. /DE reported revenue of $1.9 billion, up 40.3% from the year before. It recorded a net loss of $85.5 million. The operating loss came to $85.5 million, an operating margin of -4.4%. Over the twelve months ended Jun 30, 2026, revenue was $2.5 billion and the net loss was $18.4 million. Across the 5 fiscal years shown, revenue grew from $1.5 billion in fiscal 2021 to $1.9 billion in fiscal 2025, about 6.9% a year.
USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jun 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
|---|---|---|---|---|---|---|---|
| Revenue |
2,477
+54.0%
|
1,924
+40.3%
|
1,371
+8.8%
|
1,261
+15.0%
|
1,097
-25.5%
|
1,472
|
—
|
| Gross profit |
—
|
—
|
—
|
257
+1031.9%
|
23
+128.7%
|
-79
|
—
|
| Selling, general and administrative |
260
+39.3%
|
214
+21.4%
|
176
-3.6%
|
183
-10.1%
|
204
+9.9%
|
185
|
—
|
| Operating income |
-18
+56.4%
|
-86
-87.0%
|
-46
+77.7%
|
-205
+28.4%
|
-287
+55.0%
|
-637
-587.1%
|
-93
|
| Pretax income |
—
|
-86
|
—
|
—
|
—
|
—
|
—
|
| Income tax |
—
|
0
|
0
|
0
|
0
|
0
|
—
|
| Net income |
-18
|
-86
-98.9%
|
-43
+79.8%
|
-213
+37.2%
|
-340
+42.2%
|
-588
-330.9%
|
-136
|
| Basic EPS |
-0.04
|
—
|
—
|
-0.44
+38.0%
|
-0.71
+50.0%
|
-1.42
|
—
|
| Diluted EPS |
-0.03
|
—
|
—
|
-0.44
+38.0%
|
-0.71
+50.0%
|
-1.42
|
—
|
| Weighted average shares, basic |
519
+3.8%
|
512
+4.5%
|
490
+1.6%
|
482
+1.2%
|
476
+15.3%
|
413
|
—
|
| Weighted average shares, diluted |
527
+5.4%
|
512
+4.5%
|
490
+1.6%
|
482
+1.2%
|
476
+15.3%
|
413
|
—
|
| Other measures | |||||||
| Depreciation and amortization |
2
+23.5%
|
2
+26.7%
|
1
-47.0%
|
3
+111.4%
|
1
-4.7%
|
1
|
—
|
| EBITDA |
-16
+59.4%
|
-84
-88.8%
|
-44
+78.1%
|
-203
+29.0%
|
-285
+55.1%
|
-636
|
—
|
| Margins | |||||||
| Gross margin |
—
|
—
|
—
|
20.41%
|
2.07%
|
-5.38%
|
—
|
| Operating margin |
-0.74%
|
-4.44%
|
-3.34%
|
-16.29%
|
-26.14%
|
-43.27%
|
—
|
| Pretax margin |
—
|
-4.45%
|
—
|
—
|
—
|
—
|
—
|
| Profit margin |
-0.74%
|
-4.45%
|
-3.14%
|
-16.93%
|
-30.97%
|
-39.93%
|
—
|
| EBITDA margin |
-0.66%
|
-4.36%
|
-3.24%
|
-16.09%
|
-26.03%
|
-43.19%
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.
New to this? Read How to Read an Income Statement, With a Real Example.
Company profile
- Industry
- Hospital & Medical Service Plans (SIC 6324)
- Listed as
- CLOV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Jersey City, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1801170
- Former names
- Social Capital Hedosophia Holdings Corp. III (until Jan 7, 2021)
Other Hospital & Medical Service Plans companies
- Unitedhealth Group Inc UNH
- Elevance Health, Inc. ELV
- Cigna Group CI
- Humana Inc HUM
- Centene Corp CNC
- Molina Healthcare, Inc. MOH
- Oscar Health, Inc. OSCR
- Alignment Healthcare, Inc. ALHC
Source: SEC EDGAR filings. This is company-reported data, not investment advice.